The FGFR3-TACC3 fusion protein has been identified with differing exonic breakpoints within TACC3 in numerous cancers including glioblastoma, bladder cancer, lung adenocarcinoma, and head and neck squamous cell carcinoma [1]. The gene discussed is FGFR3; the disease is urinary bladder cancer.